Cargando…
In Vivo Oncolytic Virotherapy in Murine Models of Hepatocellular Carcinoma: A Systematic Review
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide. Current therapies often provide marginal survival benefits at the expense of undesirable side effects. Oncolytic viruses represent a novel strategy for the treatment of HCC due to their inherent ability...
Autores principales: | Ailia, Muhammad Joan, Yoo, So Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505175/ https://www.ncbi.nlm.nih.gov/pubmed/36146619 http://dx.doi.org/10.3390/vaccines10091541 |
Ejemplares similares
-
Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis
por: Bhatt, Darshak K., et al.
Publicado: (2021) -
Oncolytic virotherapy – in vivo veritas
por: Kemler, Iris, et al.
Publicado: (2018) -
Oncolytic virotherapy targeting the IL15 pathway
por: Yoo, So Young, et al.
Publicado: (2023) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012) -
Navigating through the PD-1/PDL-1 Landscape: A Systematic Review and Meta-Analysis of Clinical Outcomes in Hepatocellular Carcinoma and Their Influence on Immunotherapy and Tumor Microenvironment
por: Ailia, Muhammad Joan, et al.
Publicado: (2023)